I understand the frustration. The sandbox file links don't work as direct downloads on iPhones. Let me give you the complete answers right here in the chat - you can then simply screenshot each section or copy the text to Notes/Word.
Here are all 25 answers in clean readable format:
MS GENERAL SURGERY EXAM ANSWERS (Q37–61)
Bailey & Love's 28th Edition | ~15 min per answer
SECTION A: SHOCK & SEPSIS
Q37. Criteria of SIRS (2013, 2021)
Definition: SIRS = Systemic Inflammatory Response Syndrome - a non-specific clinical response to a severe insult (infectious or non-infectious).
Diagnostic Criteria - ANY 2 of the following 4:
| Parameter | Abnormal Value |
|---|
| Temperature | > 38°C OR < 36°C |
| Heart Rate | > 90 bpm |
| Respiratory Rate | > 20/min OR PaCO₂ < 4.3 kPa |
| WBC | > 12,000/mm³ OR < 4,000/mm³ OR > 10% bands |
Sepsis-3 Update (2016, tested 2021):
- Sepsis = life-threatening organ dysfunction from dysregulated host response to infection
- Organ dysfunction = SOFA score increase ≥ 2
- Septic shock = Sepsis + vasopressor + lactate > 2 mmol/L despite fluids
- qSOFA (bedside): RR ≥ 22, altered mentation, SBP ≤ 100 → 2 of 3 = suspect sepsis
Progression: SIRS → Sepsis → Severe Sepsis → Septic Shock → MODS
[Bailey & Love Ch.2 | Sepsis-3, JAMA 2016]
Q38. Pathogenesis of Sepsis-Induced Hypotension (2014)
Mechanism chain:
Infection → TLR/PRR activation → NF-κB → Cytokine storm (TNF-α, IL-1β, IL-6) → Cardiovascular collapse
Key steps:
- iNOS upregulation → excess Nitric Oxide → profound vasodilation → ↓ SVR
- Endothelial injury → capillary leak → intravascular hypovolaemia
- TNF-α + IL-1β → myocardial depression
- Relative adrenal insufficiency in prolonged sepsis
- Mitochondrial dysfunction → cellular dysoxia
Haemodynamic profile:
| Parameter | Early (Warm) | Late (Cold) |
|---|
| Cardiac Output | ↑ High | ↓ Low |
| SVR | ↓ Low | ↓↓ Very Low |
| Mixed venous O₂ | High | Low |
Management - Surviving Sepsis Hour-1 Bundle:
- Measure lactate (re-measure if > 2 mmol/L)
- Blood cultures × 2 before antibiotics
- Broad-spectrum antibiotics within 1 hour
- 30 mL/kg IV Hartmann's for hypotension or lactate ≥ 4
- Vasopressor if MAP < 65 mmHg → Noradrenaline (1st line)
[Bailey & Love Ch.2 | Surviving Sepsis 2021]
Q39. Distributive Shock (2014)
Definition: Maldistribution of blood flow due to pathological vasodilation → high CO + low SVR → tissue hypoperfusion despite adequate volume.
Types:
- Septic shock (most common) - NO-mediated vasodilation
- Anaphylactic shock - IgE-mediated histamine/leukotriene release
- Neurogenic shock - spinal injury T6+ → loss of sympathetic tone + bradycardia
- Toxic shock syndrome - superantigen-mediated cytokine storm
Classic haemodynamic profile:
↑ CO | ↓ SVR | ↓ PCWP | ↑ Mixed venous O₂ | Warm extremities
Management:
- Septic: Antibiotics + IV fluids + Noradrenaline
- Anaphylactic: IM Adrenaline 0.5 mg (1:1000) + IV fluids + steroids + antihistamines
- Neurogenic: IV fluids + phenylephrine + atropine for bradycardia
[Bailey & Love Ch.2, Table 2.1]
Q40. Biomarkers of Sepsis (2023)
| Biomarker | Normal | Sepsis | Role |
|---|
| Procalcitonin (PCT) | < 0.1 ng/mL | > 2 ng/mL | Diagnosis; antibiotic de-escalation |
| CRP | < 10 mg/L | > 100 mg/L | Diagnosis & monitoring |
| Lactate | < 2 mmol/L | > 2 mmol/L | Tissue hypoxia; prognosis |
| IL-6 | Low | > 1000 pg/mL | Early sepsis marker |
| Presepsin (sCD14-ST) | < 300 pg/mL | Elevated | Early macrophage activation |
| sTREM-1 | Low | Elevated | Amplifies inflammatory signal |
| Blood cultures | Sterile | Growth | Gold standard - definitive |
Procalcitonin key points:
- Rises 2-4h after bacterial infection (faster than CRP)
- Does NOT rise in viral infection or autoimmune disease
- PCT-guided therapy reduces antibiotic duration by ~3 days
- PCT < 0.5 ng/mL = consider stopping antibiotics
[Bailey & Love Ch.2 | Sepsis-3 2016]
Q41. Pathophysiology and Management of Haemorrhagic Shock
ATLS Classification:
| Class | Blood Loss | % BV | HR | BP | Urine mL/h | CNS |
|---|
| I | < 750 mL | < 15% | < 100 | Normal | > 30 | Normal |
| II | 750-1500 | 15-30% | 100-120 | Normal | 20-30 | Anxious |
| III | 1500-2000 | 30-40% | 120-140 | ↓ | 5-20 | Confused |
| IV | > 2000 mL | > 40% | > 140 | ↓↓ | < 5 | Lethargic |
Pathophysiology:
- ↓ Volume → ↓ Preload → ↓ CO → ↓ MAP
- Compensatory: ↑ HR, ↑ SVR, ADH, RAAS activation
- Prolonged: Lethal Triad = Hypothermia + Acidosis + Coagulopathy
Damage Control Resuscitation:
- Stop the bleeding - PRIMARY goal
- Permissive hypotension: MAP 50-65 mmHg until surgical control
- Haemostatic resuscitation: pRBC : FFP : Platelets = 1:1:1
- Tranexamic acid 1g IV within 3 hours (CRASH-2 trial)
- Warm fluids + warming blanket
- Calcium replacement; limit crystalloids
Endpoints: Lactate < 2 | Base excess > -6 | Urine > 0.5 mL/kg/h
[Bailey & Love Ch.2 | CRASH-2 | ATLS 10th Ed]
SECTION B: BLOOD COAGULATION
Q42. Physiology of Blood Coagulation and Its Importance in Surgery (2024)
Primary Haemostasis:
- Injury → vascular spasm → platelet adhesion (vWF to collagen via GPIb)
- Platelet activation: ADP, TXA₂, serotonin release
- GPIIb/IIIa binds fibrinogen → platelet plug
Secondary Haemostasis - Cell-Based Model:
- Initiation: TF + FVIIa → FXa + FIXa → small thrombin burst
- Amplification: thrombin activates FV, FVIII, FXI, platelets
- Propagation: tenase + prothrombinase → large thrombin burst → fibrin clot
Classic Cascade:
| Pathway | Factors | Test |
|---|
| Intrinsic | XII→XI→IX→X | APTT |
| Extrinsic | VII→X | PT/INR |
| Common | X→Thrombin→Fibrin | Both |
Fibrinolysis: tPA → plasminogen → plasmin → cleaves fibrin → FDPs/D-dimers
Surgical importance:
- Pre-op: PT, APTT, platelets, bleeding time
- Intra-op: diathermy, ligature, topical agents (Surgicel, Gelfoam)
- Post-op: DVT prophylaxis (LMWH + TED stockings) vs bleeding risk
- Drugs: Warfarin (blocks II,VII,IX,X) | Aspirin (COX-1) | NOACs
[Bailey & Love Ch.4 & Ch.2]
Q43. Coagulation Disorders and Their Management
| Disorder | Defect | PT | APTT | Plt | Treatment |
|---|
| Haemophilia A | Factor VIII ↓ | N | ↑ | N | Factor VIII conc / DDAVP |
| Haemophilia B | Factor IX ↓ | N | ↑ | N | Factor IX concentrate |
| vWD | vWF ↓ | N | ↑/N | N/↓ | DDAVP / cryoprecipitate |
| DIC | All factors consumed | ↑ | ↑ | ↓ | Treat cause + FFP + cryo + plt |
| Liver disease | ↓ factor synthesis | ↑ | ↑ | ↓ | Vit K, FFP, platelets |
| Warfarin OD | Vit K factors ↓ | ↑ | N/↑ | N | Vit K + 4-factor PCC |
| ITP | Anti-platelet Ab | N | N | ↓ | Steroids, IVIG, splenectomy |
DIC key points:
- Triggers: sepsis, trauma, obstetric emergencies, malignancy
- Lab: ↑PT, ↑APTT, ↓Fibrinogen, ↓Platelets, ↑D-dimer
- Management: TREAT THE CAUSE + FFP + cryoprecipitate + platelets
[Bailey & Love Ch.4]
Q44. Coagulopathy in Trauma Patients (2021)
Acute Traumatic Coagulopathy (ATC):
- Occurs within minutes in up to 25% of trauma patients
- 4-fold increase in mortality
- Mechanism: shock + tissue injury → protein C activation → anticoagulation + hyperfibrinolysis
Lethal Triad:
| Component | Effect | Critical Threshold |
|---|
| Hypothermia | Impairs enzymatic coagulation | < 34°C |
| Acidosis | Inhibits thrombin + platelet function | pH < 7.2 |
| Haemodilution | Dilutes clotting factors & platelets | > 10 units pRBC |
Assessment:
- ROTEM/TEG - bedside viscoelastic testing - gold standard
- Conventional: PT, APTT, fibrinogen, platelet count, D-dimer
Damage Control Resuscitation:
- 1:1:1 pRBC:FFP:Platelets (PROPPR trial)
- TXA 1g IV within 3 hours (CRASH-2)
- Cryoprecipitate if fibrinogen < 1.5 g/L
- Calcium replacement
- Damage Control Surgery: temporary pack → close → return for definitive repair
- Avoid excess crystalloid
[Bailey & Love Ch.2 | PROPPR Trial | CRASH-2]
SECTION C: BLOOD TRANSFUSION
Q45. Blood Component Separation and Their Role in Surgery (2016, 2017)
| Component | Contents | Storage | Surgical Indication |
|---|
| pRBC | RBCs, minimal plasma | 4°C, 35-42 days | Anaemia, haemorrhage (Hb < 7) |
| FFP | All clotting factors | -30°C, 1 year | DIC, massive transfusion, warfarin reversal |
| Platelets | Platelets in plasma | 22°C agitated, 5-7 days | Plt < 50k pre-op; < 10k prophylactic |
| Cryoprecipitate | FVIII, vWF, Fibrinogen, FXIII | -30°C, 1 year | Haemophilia A, vWD, DIC, TIC |
| Albumin | Colloid protein | Room temp | Hypoalbuminaemia, SBP |
| Factor Concentrates | Specific factors | Varied | Haemophilia, PCC for warfarin reversal |
Leucodepletion (universal UK since 1999): prevents FNHTR, CMV, vCJD, HLA alloimmunisation
Irradiation: prevents TA-GvHD in immunocompromised patients
[Bailey & Love Ch.4]
Q46. Blood Substitutes and Changes in Stored Blood (2011, 2023)
Storage Lesion:
| Change | Clinical Effect |
|---|
| ↓ 2,3-DPG | Left shift O₂ curve → impaired O₂ release to tissues |
| ↑ K⁺ | RBC lysis → hyperkalaemia → arrhythmias |
| ↓ pH | CO₂ + lactate accumulation → acidosis |
| ↓ Factor V, VIII | Labile factors degrade (only retained in FFP) |
| ↑ Citrate | Chelates Ca²⁺ → hypocalcaemia in massive transfusion |
| ↑ Microaggregates | Microthrombi formation |
Blood Substitutes:
- HBOCs (e.g. Hemopure): polymerised Hb, carries O₂, no crossmatch needed
- Perfluorocarbons (PFCs): dissolve O₂, require high FiO₂
- Limitations: vasoconstriction, short half-life, NOT yet in routine clinical use
- Future: recombinant Hb, nano-RBCs, universal donor RBCs
[Bailey & Love Ch.4]
Q47. Assessment of Blood Loss in a Surgical Patient (2021)
A. Clinical:
- Vital signs: HR, BP, RR, capillary refill > 2 sec, urine output
- ATLS Classes I-IV (see Q41)
- Shock Index = HR/SBP | Normal 0.5-0.7 | > 1.0 = significant haemorrhage
B. Investigations:
- FBC: Hb (note: early haemorrhage Hb may be falsely normal)
- ABG: Lactate, Base deficit (> -6 = significant shock)
- Coagulation: PT, APTT, fibrinogen
- Group & Save / Crossmatch
C. Quantitative methods:
- Swab weighing (1 g = 1 mL blood)
- Suction canister measurement
- EBL formula = EBV × (initial Hct - final Hct) / initial Hct
- EBV: 70 mL/kg adult | 80-85 mL/kg child
[Bailey & Love Ch.2 & Ch.4]
Q48. Classification, Indications and Complications of Allogeneic Blood Transfusion (2025)
Definition: Transfusion of blood from another individual.
Indications:
- Hb < 7 g/dL (< 8 in cardiac disease); Class III/IV haemorrhage
- Platelets < 10 × 10⁹/L (prophylactic) or < 50 × 10⁹/L (pre-operative)
- FFP if PT/APTT > 1.5× normal; Cryo if fibrinogen < 1.5 g/L
Pre-Transfusion Checks: ABO/Rh typing | Crossmatch | Bedside ID (2 identifiers) | Consent
Complications (SHOT Classification):
| Reaction | Mechanism | Management |
|---|
| Acute haemolytic | ABO incompatibility | STOP, fluids, frusemide, FFP |
| FNHTR | WBC antibodies | Paracetamol, slow rate |
| Anaphylaxis | IgA deficiency | Adrenaline, steroids, antihistamines |
| TACO | Volume overload | Diuretics, O₂, upright position |
| TRALI | Anti-HLA/HNA antibodies | O₂, ventilatory support, ICU |
| Septic shock | Bacterial contamination | Blood cultures, IV antibiotics |
| TA-GvHD | Donor T-cells attack host | Irradiation (PREVENTION only) |
| Iron overload | Repeated transfusion | Desferrioxamine |
[Bailey & Love Ch.4 | SHOT Annual Report]
Q49. Autologous Blood Transfusion - Types and Advantages (2021, 2022)
Definition: Collection and re-infusion of patient's own blood.
Types:
- Pre-operative autologous donation (PAD): collect 2-4 weeks before elective surgery
- Acute normovolaemic haemodilution (ANH): remove blood at start, replace with crystalloid, re-infuse at end
- Intra-operative cell salvage (ICS): suction field blood → wash → re-infuse (cardiac, vascular, orthopaedic)
- Post-operative drainage salvage: collect drain blood, filter, re-infuse within 6 hours
Advantages:
- Eliminates alloimmunisation, infection risk, TRALI, TA-GvHD
- Reduces allogeneic demand
- Fresh, 2,3-DPG replete blood (cell salvage)
- Acceptable to Jehovah's Witnesses (cell salvage)
Contraindications for cell salvage:
- Malignant field (relative) | Bowel contamination | Amniotic fluid (relative)
[Bailey & Love Ch.4]
Q50. Massive Blood Transfusion - Definition, Complications, Management (2022)
Definition (any one):
- ≥ 10 units pRBC in 24 hours
- Replacement of entire blood volume in 24 hours
-
4 units pRBC in 1 hour with anticipated continued need
Complications:
- Dilutional coagulopathy (↓ factors, ↓ platelets)
- Hypocalcaemia (citrate chelates Ca²⁺) → myocardial depression
- Hyperkalaemia → arrhythmias
- Hypothermia → enzyme inhibition
- Metabolic acidosis
- TACO, TRALI
Massive Haemorrhage Protocol (MHP):
- Activate MHP - alert haematology, blood bank, consultant
- Empiric 1:1:1 pRBC:FFP:Platelets (do NOT wait for labs)
- Tranexamic acid 1g IV stat + 1g over 8h
- Calcium gluconate 10 mL 10% IV after every 4 units pRBC
- Warm blood via in-line warmer (target > 37°C)
- ROTEM/TEG-guided product use
- Cryoprecipitate if fibrinogen < 1.5 g/L (target > 2 g/L)
- rFVIIa (NovoSeven) as last resort
[Bailey & Love Ch.4 | PROPPR Trial | CRASH-2]
Q51. Applications of Platelet-Rich Plasma (PRP) in Surgical Practice (2021)
Preparation: Autologous blood centrifuged → platelet conc 5-10× baseline (> 1 million/µL)
Growth Factors: PDGF, TGF-β, VEGF, EGF, IGF → healing, angiogenesis, collagen synthesis
Surgical Applications:
- Orthopaedics: cartilage repair, tendinopathy, bone graft enhancement
- Plastic surgery: wound healing, scar management, skin graft take
- Maxillofacial: dental implants, jaw reconstruction, sinus lifts
- Colorectal: perianal fistula treatment
- Cardiothoracic: sternal wound healing post-sternotomy
Evidence: Good for knee osteoarthritis and chronic wounds; evolving for other uses (Level IIb-III)
[Bailey & Love Ch.4]
Q52. Complications of Blood Transfusion
Mnemonic - INCH:
- Immune: haemolytic (ABO), FNHTR, urticaria, anaphylaxis, TRALI, TA-GvHD, alloimmunisation
- Infective: HIV (1:2.5M), Hep C (1:1.5M), Hep B (1:220,000), CMV, malaria, vCJD, bacterial
- Non-immune: TACO, air embolism, hypothermia, dilutional coagulopathy
- Chemical/metabolic: hyperkalaemia, hypocalcaemia, iron overload (> 20 units)
Most dangerous - Acute Haemolytic Reaction (ABO mismatch):
- Intravascular haemolysis → DIC → ARF → death
- First sign: "feeling of impending doom" / loin pain / haemoglobinuria
- Action: STOP transfusion immediately, maintain IV access, send unit + patient sample to lab
[Bailey & Love Ch.4]
Q53. Blood Products, Plasma Expanders for Polytrauma Shock; Complications of Transfusion
Blood products: See Q45 and Q48.
Crystalloids:
- Hartmann's/Ringer's lactate - balanced, preferred in trauma
- Normal saline - risk of hyperchloraemic acidosis with large volumes
- Dextrose - NOT for resuscitation (hypotonic, worsens cerebral oedema)
Colloids:
- Human albumin solution (HAS 4-5%): liver failure, SBP
- Gelatin (Gelofusine): half-life 2-3h, anaphylaxis risk
- AVOID HES/Voluven in sepsis (CHEST trial: ↑ mortality + AKI)
Principles for Polytrauma:
- Permissive hypotension (MAP 50-65) until surgical haemostasis
- 1:1:1 haemostatic resuscitation + TXA early + Calcium + warm fluids
- Minimal crystalloid to avoid dilutional coagulopathy
[Bailey & Love Ch.2 & Ch.4 | ATLS 10th Ed]
Q54. TRALI - Definition, Mechanism and Management (2021)
Definition: New acute lung injury within 6 hours of transfusion, with PaO₂/FiO₂ < 300 mmHg, bilateral pulmonary infiltrates on CXR, NO evidence of pre-existing ALI or TACO.
Mechanism - Two-Hit Model:
- Hit 1: Patient's condition primes pulmonary neutrophils (surgery, sepsis, trauma)
- Hit 2: Donor anti-HLA (class I/II) or anti-HNA antibodies activate primed neutrophils
- Neutrophil activation → ROS + proteases → endothelial damage → capillary leak → non-cardiogenic pulmonary oedema
- Most implicated: FFP and platelets from multiparous female donors
TRALI vs TACO:
| Feature | TRALI | TACO |
|---|
| Mechanism | Non-cardiogenic (Ab-mediated) | Cardiogenic (volume overload) |
| JVP/CVP | Normal/↓ | Elevated |
| Response to diuretics | No | Yes |
| BNP | Normal | Elevated |
| CXR | Bilateral infiltrates, no effusion | Bilateral infiltrates + effusion |
Management:
- STOP transfusion immediately
- High-flow O₂; escalate to CPAP/BiPAP or mechanical ventilation
- Lung-protective ventilation (6 mL/kg + PEEP)
- NO diuretics (not volume overload)
- Report to blood bank and SHOT
- Prevention: male-only / nulliparous donors for plasma products
[Bailey & Love Ch.4 | SHOT Report 2023]
SECTION D: ANAESTHESIA & CRITICAL CARE
Q55. Pharmacological Advances in Local Anaesthetics (2015)
Mechanism: Reversibly block voltage-gated Na⁺ channels. Block order: autonomic > sensory > motor.
| Agent | Type | Max Dose | Duration | Uses |
|---|
| Lidocaine | Amide | 3 mg/kg (7 with adrenaline) | 1-2h | Infiltration, IVRA, topical |
| Bupivacaine | Amide | 2 mg/kg | 4-8h | Spinal, epidural, PNB |
| Levobupivacaine | Amide | 2.5 mg/kg | 4-8h | Safer cardiac profile |
| Ropivacaine | Amide | 3 mg/kg | 4-6h | Epidural, less motor block |
| Prilocaine | Amide | 6 mg/kg | 2-3h | Bier's block |
| Cocaine | Ester | 1.5 mg/kg topical | 1h | ENT topical (vasoconstriction) |
Advances:
- Liposomal bupivacaine (Exparel): sustained release up to 72h
- Ultrasound-guided blocks: greater accuracy, fewer complications
- Continuous PNB catheters: improved post-op analgesia
- Adjuvants: dexamethasone (prolongs block 4-8h), dexmedetomidine, clonidine
- EMLA cream: lidocaine 2.5% + prilocaine 2.5% for venepuncture
LAST (Local Anaesthetic Systemic Toxicity):
- CNS: perioral tingling → tinnitus → seizures → coma
- Cardiac: arrhythmias → cardiac arrest (bupivacaine worst)
- Treatment: STOP, 100% O₂, 20% Intralipid 1.5 mL/kg IV bolus
[Bailey & Love Ch.14]
Q56. Regional Anaesthesia (2006)
Definition: Interruption of nerve conduction over a body region using LA without loss of consciousness.
Types:
- Central neuraxial: Spinal, Epidural, Caudal
- Peripheral nerve blocks: brachial plexus, femoral, sciatic, ankle
- IV regional (Bier's block): upper limb surgery
- Plexus blocks, field blocks, wound infiltration
Spinal vs Epidural:
| Feature | Spinal | Epidural |
|---|
| Space | Subarachnoid (CSF) | Epidural space |
| Drug volume | Small (2-4 mL) | Large (10-20 mL) |
| Onset | Fast (2-5 min) | Slow (15-20 min) |
| Duration | Fixed (2-4h) | Continuous (catheter) |
| Level | L2/3 or L3/4 | Any level |
| Dural puncture | Yes (intentional) | Accidental = PDPH |
| Uses | Lower limb, perineal | Labour, post-op analgesia |
Advantages over GA:
- Avoids airway instrumentation
- Better post-op analgesia, ↓ opioid, ↓ PONV
- Earlier mobilisation, shorter hospital stay
- Preferred in high-risk cardiac/respiratory patients
[Bailey & Love Ch.14]
Q57. Short Note on Epidural Anaesthesia
Anatomy: Space between ligamentum flavum and dura mater (fat, epidural veins, lymphatics). Extends foramen magnum to sacral hiatus.
Technique:
- Position: sitting or lateral decubitus
- Needle: Tuohy 16-18G, bevel upward
- Identification: loss of resistance to saline
- Catheter: 3-4 cm into epidural space
- Test dose: 3 mL lignocaine 2% + adrenaline (detect intrathecal/intravascular placement)
Drugs: Bupivacaine 0.1-0.5% ± fentanyl/morphine
- Low concentration = sensory block (labour)
- High concentration = motor + sensory (surgery)
Complications:
- PDPH (dural puncture headache): postural, Rx = bed rest, caffeine, blood patch
- High spinal: hypotension, bradycardia, respiratory arrest
- Hypotension: IV fluids + ephedrine 6 mg IV
- Epidural haematoma: back pain → paraplegia → emergency MRI + decompression
- Epidural abscess: fever + neuro deficit → MRI + IV antibiotics ± drainage
Uses: Labour analgesia | Major abdominal/thoracic/lower limb surgery | PCE (post-op)
[Bailey & Love Ch.14]
Q58. Incentive Spirometry (2008)
Definition: Respiratory therapy device that encourages slow, deep, sustained inspiratory efforts to prevent/treat atelectasis by providing visual feedback of inspired volume.
Mechanism:
- Diaphragmatic breathing → opens collapsed alveoli → ↑ FRC
- Sustains flow-volume loop → recruits atelectatic segments
Types:
- Volume-oriented (preferred): measures inspired volume (Voldyne) - target > 2500 mL
- Flow-oriented: visual balls indicating flow rate
Indications:
- Post-operative (especially upper abdominal/thoracic surgery)
- COPD, pneumonia, neuromuscular disease, atelectasis
- Pre-op conditioning in high-risk patients
Technique:
Sit upright → exhale normally → seal lips → inhale slowly and deeply → hold 5-10 seconds → 10 breaths/hour while awake
Benefits: ↓ post-op pneumonia and atelectasis | Improves FVC, FEV₁, SpO₂
[Bailey & Love Ch.14]
Q59. Management of Cardiac Arrest During Surgery (2023)
Reversible Causes - 4Hs and 4Ts:
- 4H: Hypoxia | Hypovolaemia | Hypo/Hyperkalaemia | Hypothermia
- 4T: Tension pneumothorax | Tamponade | Thrombosis (PE/MI) | Toxins
Surgical-Specific Causes:
- Massive haemorrhage | Vagal reactions | Air embolism
- Malignant Hyperthermia (MH) | LAST | Cement implantation syndrome
Immediate Management (ALS Algorithm):
- Recognise: unresponsive, no pulse, no normal breathing
- Call crash team
- CPR: 30:2, 100-120 bpm, 5-6 cm depth
- Intubate early (anaesthetist present)
- Adrenaline 1 mg IV every 3-5 min
- Shockable (VF/pVT): defibrillate 200J biphasic immediately
- Amiodarone 300 mg IV after 3rd shock
- Non-shockable (PEA/Asystole): CPR + adrenaline + treat reversible causes
Special Situations:
- Malignant Hyperthermia: STOP trigger agent, Dantrolene 2.5 mg/kg IV, active cooling
- LAST: 20% Intralipid 1.5 mL/kg IV bolus
- Tension pneumothorax: needle decompression 2nd ICS MCL → chest drain
- Air embolism: left lateral Trendelenburg, aspirate via CVP, 100% O₂
[Bailey & Love Ch.14 | ALS Guidelines 2021]
Q60. Pain Relief in Surgery / Post-Operative Pain Management (2009, 2011)
WHO Analgesic Ladder:
- Step 1 (Mild): Paracetamol 1g QDS + NSAIDs (ketorolac, ibuprofen)
- Step 2 (Moderate): Weak opioids - codeine, tramadol ± adjuvants
- Step 3 (Severe): Strong opioids - morphine, fentanyl, oxycodone
Multimodal Analgesia (gold standard):
Paracetamol + NSAID + Regional block + Opioid PRN → reduces opioid consumption
| Drug | Mechanism | Dose | Notes |
|---|
| Paracetamol | Central COX inhibition | 1g QDS IV/PO | Safe, start ASAP |
| NSAIDs | COX-1/2 inhibition | Ketorolac 15-30 mg | Caution: renal, GI, bleeding |
| Morphine | µ opioid receptor | 0.1 mg/kg IV titrated | Gold standard severe pain |
| Fentanyl | µ agonist rapid onset | 1-2 mcg/kg IV | Patch for chronic pain |
| Gabapentin | Ca²⁺ channel (α₂δ) | 300 mg TDS | Reduces opioid use |
| Ketamine | NMDA antagonist | 0.1-0.5 mg/kg | Opioid-sparing |
Delivery methods:
- PCA: IV morphine 1 mg bolus, 5 min lockout - safe, patient autonomy
- Epidural (PCE): bupivacaine ± fentanyl - best for thoracic/abdominal surgery
- TAP block: somatic pain after abdominal surgery
ERAS principles: Pre-emptive analgesia | Minimal opioids | Early mobilisation
[Bailey & Love Ch.14]
Q61. Invasive and Non-Invasive Techniques of Post-Operative Analgesia (2021)
NON-INVASIVE:
- Oral: paracetamol, NSAIDs, opioids, gabapentinoids, ketamine
- Transdermal: fentanyl patch (72h), buprenorphine
- Inhaled (Entonox): 50% N₂O + 50% O₂ - labour, dressing changes
- TENS: gate control theory - mild/moderate pain
- Ice/cold therapy: local anti-inflammatory analgesia
INVASIVE:
- IV PCA: morphine 1 mg bolus, 5 min lockout
- Epidural (PCE): bupivacaine + fentanyl via catheter - gold standard major surgery
- Spinal opioids: intrathecal morphine 0.1-0.3 mg - 12-24h analgesia
- Peripheral nerve blocks:
- TAP block - abdominal surgery
- Femoral nerve block - hip/knee
- Sciatic nerve block - foot/ankle
- Brachial plexus block - upper limb
- Intercostal block - rib fractures, thoracotomy
- Paravertebral block - mastectomy, thoracic surgery (unilateral)
- Continuous wound infusion catheters
- Intra-articular injection: bupivacaine (knee arthroscopy)
Monitoring: Pain NRS 0-10 | Sedation score | Respiratory rate | PONV
[Bailey & Love Ch.14]
All 25 answers complete. Source: Bailey & Love's Short Practice of Surgery, 28th Edition, Chapters 2, 4, and 14.
To save these on your iPhone, you have a few simple options:
- Take screenshots - scroll through and screenshot each section
- Copy all text - press and hold → Select All → Copy → paste into Apple Notes or Pages
- Share this chat - tap the share icon in your browser and save the page as a bookmark or PDF via Safari's share sheet (tap Share → "Options" → "PDF" → Save to Files)